An increasing number of Pfizer and Moderna investors are dumping their shares in the COVID-19 vaccine manufacturers’ stocks as more nations scrap their vaccine mandates.
Reports reveal that Moderna has fallen 70 per cent from its peak, resulting in a 140 billion USD loss, while Pfizer is down 19 per cent.
Until now, Pfizer, the 29th largest corporation worldwide, had record earnings per share and a market capitalisation of around 270 billion USD, primarily due to sales of its experimental COVID-19 vaccine. The company’s antiviral medicines, like Paxlovid, have been expected to earn 22 billion USD in 2022.
Wells Fargo & Company, an American multinational financial services company, even predicted late last year that Pfizer could dominate the COVID-19 market in the years to come.
However, Pfizer lost 20 billion USD in market capitalisation on February 8, 2022, after its record earnings failed to meet expectations.
Blackrock Executive Edward Dowd, considered a top Wall Street insider, predicts that Moderna will fall to zero dollars per share. At the same time, he predicts Pfizer will plummet to ten dollars per share or less once lawsuits emerge against the companies for fraud involving concealing the fatal side effects of their experimental mRNA COVID-19 vaccines.
“Those of you who still think nothing’s going on, you don’t want to be what I call the bag holder. You don’t want to be the guy taking the fourth jab booster and holding these stocks (on their way) down. Moderna’s going to zero. I think Pfizer goes sub ten dollars once the lawsuits come out,” said Mr Dowd.
Although Big Pharma giants appear to be immune from legal responsibility for COVID-19 vaccine injuries or deaths due to government protections, like the US Emergency Use Authorisation (EUA), fraud will void these protections against lawsuits.
“Pfizer got blanket immunity with EUA. If fraud occurred, to my mind and what I’m seeing from their refusal to release the data, if there is fraud and it comes out, and we need whistleblowers, and it’s looking more apparent that this product is deadly, fraud eviscerates all contracts. That’s case law. So you go down the daisy chain, and that’s liability. That’s bankruptcy for Moderna, definitely Pfizer,” stated Mr Dowd.
Considering the increasing number of non-COVID related deaths reported by insurance companies since the vaccine rollout began, the avalanche of lawsuits against the Big Pharma giants may be very close.
Following American insurance company OneAmerica’s shocking report of a 40 per cent increase in non-COVID deaths in younger working-class employees, other insurance firms worldwide have reported similar rises in non-COVID deaths since the first vaccine rollouts in 2021.
“Unum Insurance is up 36 per cent, Lincoln National plus 57 per cent, Prudential plus 41 per cent, Reinsurance Group of America plus 21 per cent, Hartford plus 32 per cent, Met Life plus 24 per cent, and Aegon, which is a Dutch insurer, saw in their US arm plus 57 per cent in the 4th quarter – in the 3rd quarter they saw a 258 per cent increase in death claims,” noted Mr Dowd.
“The bodies are piling up.”
